Urteste plans to start clinical trials for its pancreatic cancer test in Europe in Q3 2025
27 MARCH 2025 PRESS RELEASE Urteste plans to start clinical trials for its…
CervoMed Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Updates
March 17, 2025 08:00 ET | Source: CervoMed Inc. -Reported positive 16-week…
Zentalis Pharmaceuticals Presents Updated Clinical Data at the Society of Gynecologic Oncology 2025 Annual Meeting on Womens Cancer
March 15, 2025 11:25 ET | Source: ZENTALIS PHARMACEUTICALS Azenosertib median duration…
Apogee Therapeutics Announces Positive Interim Phase 1 Results from the APG990 Healthy Volunteer Trial, Unlocking Potential Maintenance Dosing Every Three and Six Months for APG279 (APG777 + APG990)
Interim Phase 1 results for APG990, a novel half-life extended OX40L antibody,…
Continuous Biomarker Monitoring Pioneer Proton Intelligence Inc Announces a $6.95 Million Seed Raise to Initiate Human Trials for Potassium Monitoring in Patients With Kidney Disease
VANCOUVER, British Columbia & MELBOURNE, Australia--(BUSINESS WIRE)--Proton Intelligence Inc., developing the first-ever…
French Biotech Company AdipoPharma Secures Funding to Initiate Clinical Trials for its first-in-class compound for Insulin Resistance
STRASBOURG, France, Nov. 11, 2024 (GLOBE NEWSWIRE) -- AdipoPharma, a biotech company…